56921-85-8Relevant articles and documents
DIAZABICYCLIC SUBSTITUTED IMIDAZOPYRIMIDINES AND THEIR USE FOR THE TREATMENT OF BREATHING DISORDERS
-
Paragraph 0245; 0478-0481; 0482, (2020/04/29)
The present invention relates to novel diazabicyclically substituted imidazo[1,2-a]pyrimidine derivatives, to methods for producing the same, to the use thereof either alone or in combinations for the treatment and/or prevention of diseases, as well as to
Imidazo[1,2-A]pyrimidine-containing compounds, method for preparing the same, and their use in electronic devices
-
Page/Page column 5, (2016/06/06)
The present disclosure describes novel imidazo[1,2-a]pyrimidine-containing organic light-emitting compounds represented by formula (I): wherein R1 and R2 independently represent hydrogen, an alkyl group, or an aryl group which is uns
Hypervalent iodine(III) sulfonate mediated synthesis of 2-arylimidazo[1,2-a]pyrimidines in liquid PEG-400
Cheng, Hui-Ting,Hou, Rei-Sheu,Wang, Huey-Min,Kang, Iou-Jiun,Lin, Pei-Ying,Chena, Ling-Ching
experimental part, p. 632 - 635 (2010/06/13)
PEG-400[poly(ethylene glycol-400)] is used as a "green" recyclable solvent in the one-pot synthesis of 2-arylimidazo[1,2-a]pyrimidines by reaction with ketones, [hydroxyl(2,4-dinitrobenzenesulfonyloxy)-iodo]benzene (HDNIB), and 2-aminopyrimidine. Signific